Life Time vs Uncommon Therapeutics

Side-by-side comparison of AI visibility scores, market position, and capabilities

Life Time leads in AI visibility (68 vs 27)

Life Time

ChallengerFitness & Wellness

Premium Fitness

Premium athletic country club with 170 locations and $2.5B revenue; destination fitness facilities with spa, childcare, and pickleball courts targeting affluent suburban families.

AI VisibilityBeta
Overall Score
B68
Category Rank
#1 of 1
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
63
Perplexity
60
Gemini
67

About

Life Time Fitness (Life Time) is a premium health and wellness brand operating large-scale "athletic country clubs" across the United States and Canada, combining fitness, spa, childcare, racquet sports, rock climbing, and healthy food in destination facilities that average 100,000+ square feet. Founded in 1992 by Bahram Akradi in Chanhassen, Minnesota and listed on NYSE since 2021, Life Time operates approximately 170 locations and generates approximately $2.5 billion in annual revenue with membership fees typically ranging from $200-400+ per month for families.

Full profile

Uncommon Therapeutics

EmergingHealthcare

General

Rare disease biotech developing polytherapy approach for Rett Syndrome (1 in 10,000 girls); founder-developed protocol validated through personal patient experience competing with Acadia Pharmaceuticals Daybue in Rett market.

AI VisibilityBeta
Overall Score
D27
Category Rank
#1121 of 1167
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
28
Perplexity
33
Gemini
36

About

Uncommon Therapeutics is a biotech company founded by Noah Auerhahn — directly inspired by his daughter's diagnosis with Rett Syndrome, a severe genetic neurological disease affecting approximately 1 in 10,000 girls — applying a polytherapy approach (combining multiple therapeutic agents targeting different disease mechanisms simultaneously) to develop treatments for serious neurological and rare diseases. After improving his daughter's quality of life through a personally developed polytherapy protocol, Auerhahn founded Uncommon Therapeutics to translate these insights into pharmaceutical products for the broader Rett Syndrome patient community.

Full profile

AI Visibility Head-to-Head

68
Overall Score
27
#1
Category Rank
#1121
72
AI Consensus
67
stable
Trend
stable
63
ChatGPT
28
60
Perplexity
33
67
Gemini
36
71
Claude
22
61
Grok
33

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.